^
Association details:
| Biomarker: | EGFR V786M |
|---|---|
| Cancer: | Lung Adenocarcinoma |
| Drug Class: | EGFR inhibitor |
| Direction: | Sensitive |
Evidence:
Source:
Title:
A Lung Cancer Patient Harboring a Rare Oncogenic EGFR Exon 20 V786M Mutation Responded to a Third-Generation Tyrosine Kinase Inhibitor: Case Report and Review of the Literature
Published date:
05/18/2022
Excerpt:
A 69-year-old woman was diagnosed with adenocarcinoma cT4N2M1c, stage IVB. Next-generation sequencing (NGS) confirmed a rare EGFR V786M mutation...Subsequent third-generation EGFR TKI showed a remarkable therapeutic effect.
DOI:
https://doi.org/10.3389/fonc.2022.912426
